These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7588148)

  • 1. Experimental immunization against cutaneous leishmaniasis using Leishmania major subcellular fractions alone or in combination with Phlebotomus duboscqi gut antigens.
    Mbati PA; Anjili CO; Lugalia R; Mwanyumba P; Tonui WK; Robert LL; Githure JI
    East Afr Med J; 1995 Aug; 72(8):519-22. PubMed ID: 7588148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania major infections in Phlebotomus duboscqi fed on murine models immunized with L. major subcellular antigens and sandfly gut antigens.
    Mbati PA; Anjili CO; Odongo S; Ogaja P; Tonui W
    Onderstepoort J Vet Res; 2000 Mar; 67(1):57-63. PubMed ID: 10843323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae).
    Anjili C; Langat B; Ngumbi P; Mbati PA; Githure J; Tonui WK
    East Afr Med J; 2006 Feb; 83(2):72-8. PubMed ID: 16708877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect against Leishmania infection conferred by sand fly bites is limited to short-term exposure.
    Rohoušová I; Hostomská J; Vlková M; Kobets T; Lipoldová M; Volf P
    Int J Parasitol; 2011 Apr; 41(5):481-5. PubMed ID: 21310158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
    Tonui WK; Titus RG
    Am J Trop Med Hyg; 2007 Mar; 76(3):579-84. PubMed ID: 17360887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
    Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
    Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
    Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi.
    Gomes R; Teixeira C; Oliveira F; Lawyer PG; Elnaiem DE; Meneses C; Goto Y; Bhatia A; Howard RF; Reed SG; Valenzuela JG; Kamhawi S
    PLoS Negl Trop Dis; 2012; 6(4):e1610. PubMed ID: 22509423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes.
    Badiee A; Jaafari MR; Khamesipour A
    Exp Parasitol; 2007 Feb; 115(2):127-34. PubMed ID: 16979165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S; Soto M; Carrión J; Alonso C; Requena JM
    Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania transmission-blocking vaccines: a review.
    Tonui WK
    East Afr Med J; 1999 Feb; 76(2):93-6. PubMed ID: 10442130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania.
    Al-Wabel MA; Tonui WK; Cui L; Martin SK; Titus RG
    Am J Trop Med Hyg; 2007 Dec; 77(6):1060-5. PubMed ID: 18165522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinations with live-attenuated Leishmania major promastigotes and challenge infection with L. major in BALB/c mice.
    Onyalo JA; Mwala DM; Anjili CO; Orago AS; Tonui WK
    East Afr Med J; 2005 Apr; 82(4):193-7. PubMed ID: 16122087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.
    Zadeh-Vakili A; Taheri T; Taslimi Y; Doustdari F; Salmanian AH; Rafati S
    Vaccine; 2004 May; 22(15-16):1930-40. PubMed ID: 15121305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
    Mbow ML; Bleyenberg JA; Hall LR; Titus RG
    J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phlebotomus papatasi exposure cross-protects mice against Leishmania major co-inoculated with Phlebotomus duboscqi salivary gland homogenate.
    Lestinova T; Vlkova M; Votypka J; Volf P; Rohousova I
    Acta Trop; 2015 Apr; 144():9-18. PubMed ID: 25597641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life-long systemic protection in mice vaccinated with L. major and adenovirus IL-12 vector requires active infection, macrophages and intact lymph nodes.
    Gabaglia CR; Sercarz EE; Diaz-De-Durana Y; Hitt M; Graham FL; Gauldie J; Braciak TA
    Vaccine; 2004 Nov; 23(2):247-57. PubMed ID: 15531044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania major: targeting IL-4 in successful immunomodulation of murine infection.
    Wakil AE; Wang ZE; Locksley RM
    Exp Parasitol; 1996 Nov; 84(2):214-22. PubMed ID: 8932771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages.
    Shimizu Y; Takagi H; Nakayama T; Yamakami K; Tadakuma T; Yokoyama N; Kojima N
    Parasite Immunol; 2007 May; 29(5):229-39. PubMed ID: 17430546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.